124 related articles for article (PubMed ID: 33273146)
1. Dibenzoate esters of cis-tetralin-2,3-diol as analogs of (-)-epigallocatechin gallate: synthesis and crystal structure of anticancer drug candidates.
Rutherford RN; Ura S; Chan TH; Fukumoto K; Nishioka T; Renzetti A
Acta Crystallogr C Struct Chem; 2020 Dec; 76(Pt 12):1085-1095. PubMed ID: 33273146
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of a 3,4,5-trimethoxybenzoyl ester analogue of epigallocatechin-3-gallate (EGCG): a potential route to the natural product green tea catechin, EGCG.
Zaveri NT
Org Lett; 2001 Mar; 3(6):843-6. PubMed ID: 11263896
[TBL] [Abstract][Full Text] [Related]
3. Enantioselective synthesis of epigallocatechin-3-gallate (EGCG), the active polyphenol component from green tea.
Li L; Chan TH
Org Lett; 2001 Mar; 3(5):739-41. PubMed ID: 11259050
[TBL] [Abstract][Full Text] [Related]
4. Offset pi-pi interaction in crystal structure of (-)-gallocatechin-3-O-gallate.
Tsutsumi H; Sato T; Ishizu T
Chem Pharm Bull (Tokyo); 2010 Apr; 58(4):572-4. PubMed ID: 20410646
[TBL] [Abstract][Full Text] [Related]
5. Novel epigallocatechin gallate analogs as potential anticancer agents: a patent review (2009 - present).
Landis-Piwowar K; Chen D; Foldes R; Chan TH; Dou QP
Expert Opin Ther Pat; 2013 Feb; 23(2):189-202. PubMed ID: 23230990
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of synthetic analogs of (-)-epigallocatechin-3-gallate as proteasome inhibitors.
Kazi A; Wang Z; Kumar N; Falsetti SC; Chan TH; Dou QP
Anticancer Res; 2004; 24(2B):943-54. PubMed ID: 15161048
[TBL] [Abstract][Full Text] [Related]
7. Molecular Capture Using the Precipitate of Creaming-Down by (-)-Epigallocatechin-3-O-gallate.
Tsutsumi H; Sato A; Fujino S; Fujioka Y; Ishizu T
Chem Pharm Bull (Tokyo); 2019; 67(5):501-504. PubMed ID: 31061378
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of Creaming Down Based on Chemical Characterization of a Complex of Caffeine and Tea Catechins.
Ishizu T; Tsutsumi H; Sato T
Chem Pharm Bull (Tokyo); 2016; 64(7):676-86. PubMed ID: 27373623
[TBL] [Abstract][Full Text] [Related]
9. Novel mechanisms of anticancer activities of green tea component epigallocatechin- 3-gallate.
Zhang L; Wei Y; Zhang J
Anticancer Agents Med Chem; 2014; 14(6):779-86. PubMed ID: 24851882
[TBL] [Abstract][Full Text] [Related]
10. In Vitro and In Silico Studies of the Molecular Interactions of Epigallocatechin-3-
Saeki K; Hayakawa S; Nakano S; Ito S; Oishi Y; Suzuki Y; Isemura M
Molecules; 2018 May; 23(6):. PubMed ID: 29843451
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of interaction between risperidone and tea catechin (2) influence of presence of galloyl group in catechin on insoluble complex formation with risperidone].
Ikeda H; Moriwaki H; Matsubara T; Yukawa M; Iwase Y; Yukawa E; Aki H
Yakugaku Zasshi; 2012; 132(1):145-53. PubMed ID: 22214589
[TBL] [Abstract][Full Text] [Related]
12. A novel long-chain acyl-derivative of epigallocatechin-3-O-gallate prepared and purified from green tea polyphenols.
Chen P; Tan Y; Sun D; Zheng XM
J Zhejiang Univ Sci; 2003; 4(6):714-8. PubMed ID: 14566988
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibition in human breast cancer cells with high catechol-O-methyltransferase activity by green tea polyphenol EGCG analogs.
Huo C; Yang H; Cui QC; Dou QP; Chan TH
Bioorg Med Chem; 2010 Feb; 18(3):1252-8. PubMed ID: 20045338
[TBL] [Abstract][Full Text] [Related]
14. Configurational studies of complexes of tea catechins with caffeine and various cyclodextrins.
Ishizu T; Kajitani S; Tsutsumi H; Sato T; Yamamoto H; Hirata C
Planta Med; 2011 Jul; 77(11):1099-109. PubMed ID: 21472646
[TBL] [Abstract][Full Text] [Related]
15. Association of Catechin Molecules in Water: Quantitative Binding Study and Complex Structure Analysis.
Ujihara T; Hayashi N
J Nat Prod; 2016 Jan; 79(1):66-73. PubMed ID: 26720794
[TBL] [Abstract][Full Text] [Related]
16. Properties of precipitate of creaming down by (-)-epigallocatechin-3-O-gallate and caffeine.
Ishizu T; Tsutsumi H; Kinoshita Y; Mukaida H; Sato T; Kajitani S
Chem Pharm Bull (Tokyo); 2014; 62(6):552-8. PubMed ID: 24881661
[TBL] [Abstract][Full Text] [Related]
17. Catechin prodrugs and analogs: a new array of chemical entities with improved pharmacological and pharmacokinetic properties.
Bansal S; Vyas S; Bhattacharya S; Sharma M
Nat Prod Rep; 2013 Oct; 30(11):1438-54. PubMed ID: 24056761
[TBL] [Abstract][Full Text] [Related]
18. The challenge of developing green tea polyphenols as therapeutic agents.
Huo C; Wan SB; Lam WH; Li L; Wang Z; Landis-Piwowar KR; Chen D; Dou QP; Chan TH
Inflammopharmacology; 2008 Oct; 16(5):248-52. PubMed ID: 18815735
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Biological Testing of Novel Glucosylated Epigallocatechin Gallate (EGCG) Derivatives.
Zhang X; Wang J; Hu JM; Huang YW; Wu XY; Zi CT; Wang XJ; Sheng J
Molecules; 2016 May; 21(5):. PubMed ID: 27187321
[TBL] [Abstract][Full Text] [Related]
20. Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer.
Almatroodi SA; Almatroudi A; Khan AA; Alhumaydhi FA; Alsahli MA; Rahmani AH
Molecules; 2020 Jul; 25(14):. PubMed ID: 32660101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
